Johnson & Johnson sell Biotechhunter
Summary
This prediction ended on 15.07.21 with a price of €142.82. The SELL prediction by Biotechhunter finished with a performance of 20.89%. A total of €2.55 was paid as dividends for this prediction. Biotechhunter has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Johnson & Johnson | 2.780% | 2.780% | -5.581% | 2.164% |
iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
Comments by Biotechhunter for this prediction
In the thread Johnson & Johnson diskutieren